Robert E. Landry

Insider Reports History

Entity
Individual
Location
777 Old Saw Mill River Road, Tarrytown, New York
Signature
/s/**Robert E. Landry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert E. Landry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Common Stock 23,693 $22.7 M $956.65 Feb 2, 2024 Direct
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Common Stock 270 $252 K $934.71 Feb 2, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP Finance CFO Non-Qualified Stock Option (right to buy) 11,787 Feb 2, 2024 Direct

Insider Reports Filed by Robert E. Landry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Feb 2, 2024 3 -117,227 4 Feb 6, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 31, 2024 3 -117,272 4 Feb 2, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 23, 2024 6 -464,512 4 Jan 25, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 17, 2024 3 -140,558 4 Jan 18, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 12, 2024 3 -224,022 4 Jan 17, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 4, 2024 3 -124,141 4 Jan 8, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 6 -338,439 4 Jan 4, 2024 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 27, 2023 6 -407,916 4 Dec 29, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 12, 2023 4 -5,717,506 4 Dec 14, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2023 3 -3,573,573 4 Dec 12, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Aug 23, 2023 1 -188,212 4 Aug 25, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Mar 27, 2023 22 -1,841,829 4 Mar 29, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Feb 3, 2023 18 -1,753,048 4 Feb 7, 2023 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2022 2 0 4 Dec 20, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2022 4 -962,523 4 Dec 12, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 1, 2022 6 -943,825 4 Dec 2, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Oct 31, 2022 13 -741,929 4 Nov 2, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Oct 14, 2022 4 -541,258 4 Oct 18, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Apr 7, 2022 28 -3,276,534 4 Apr 11, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Mar 31, 2022 5 -450,357 4 Apr 1, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Mar 28, 2022 29 -3,758,253 4 Mar 30, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Mar 21, 2022 4 -270,821 4 Mar 23, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Mar 16, 2022 5 -315,832 4 Mar 18, 2022 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 10, 2021 5 -625,837 4 Dec 14, 2021 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2021 21 -1,101,437 4 Dec 10, 2021 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Nov 16, 2021 4 -941,470 4 Nov 18, 2021 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Aug 31, 2021 3 -63,333 4 Sep 1, 2021 EVP Finance CFO
REGN REGENERON PHARMACEUTICALS, INC. Aug 6, 2021 22 -1,159,116 4 Aug 10, 2021 EVP Finance CFO